Diseases, Conditions, Syndromes

Siponimod cuts risk of disability progression in multiple sclerosis

(HealthDay)—For patients with secondary progressive multiple sclerosis, the selective sphingosine 1-phosphate (S1P) receptor1,5 modulator, siponimod, is associated with reduced relative risk of confirmed disability progression, ...

Immunology

Grass peptide immunotherapy cuts seasonal allergy symptoms

(HealthDay)—Immunotherapy with peptide hydrolysates from Lolium perenne (LPP) reduces seasonal allergy symptoms and is generally well tolerated, according to a study published online March 7 in Allergy.

Surgery

Novel use for drug reduces post-operative nausea and vomiting

An innovative use for a known drug is showing promise as an effective treatment for preventing postoperative nausea and vomiting (PONV), suggests a study published today in the Online First edition of Anesthesiology, the ...

page 6 from 23